Boya Xiao

发表

A pooled analysis of adding olanzapine to guideline-recommended antiemetic therapy for breast cancer patients treated with an anthracycline and cyclophosphamide in prospective and retrospective studies

Tong Su, Yun-xiang Tang, Bi-Cheng Wang, 2021, Supportive Care in Cancer.

Oral Versus Intravenous Chemotherapy in COVID-19 Epidemic

Boya Xiao, Bicheng Wang, Bicheng Wang, 2021, Diseases & Research.

A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone

Quentin Liu, Liangliang Shi, Bi-Cheng Wang, 2022, PloS one.

The efficacy and safety of cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: A comparative analysis of retrospective studies versus prospective studies

Bi-Cheng Wang, Boya Xiao, Guo-He Lin, 2022, Dermatologic therapy.

The E cacy of Olanzapine-Contained Antiemetic Therapy for Breast Cancer Patients: A Systematic Review and Pooled Analysis

Boya Xiao, Zhaonan Liu, 2021 .

Efficacy and safety of gemcitabine plus capecitabine in the treatment of advanced or metastatic pancreatic cancer: a systematic review and meta-analysis.

Bi-Cheng Wang, Boya Xiao, Guo-He Lin, 2020, Annals of palliative medicine.

The efficacy and safety of PD-1/PD-L1 inhibitors in breast cancer: a systematic review and meta-analysis

Bi-Cheng Wang, Boya Xiao, Guo-He Lin, 2020, Translational cancer research.

A tolerability and safety analysis of adding granulocyte-macrophage colony-stimulating factor to local radiotherapy in a case series of seven patients with thoracic cancer.

Quentin Liu, Bi-Cheng Wang, Zhan-jie Zhang, 2021, Annals of palliative medicine.

Clinical Progress of Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Zhan-jie Zhang, Boya Xiao, Bicheng Wang, 2021, Diseases & Research.

Risk Factors for Survival in Patients With Medulloblastoma: A Systematic Review and Meta-Analysis

Sen Li, Boya Xiao, Jiangang Liu, 2022, Frontiers in Oncology.

Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

Quentin Liu, Bi-Cheng Wang, Boya Xiao, 2020, Journal of oncology.

The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis

Quentin Liu, Bi-Cheng Wang, Boya Xiao, 2020, BMC Cancer.

Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials

Bi-Cheng Wang, Boya Xiao, Guo-He Lin, 2021, Frontiers in Oncology.

6 versus 12 months of adjuvant trastuzumab in HER2+ early breast cancer

Quentin Liu, Boya Xiao, Guo-He Lin, 2021, Medicine.

Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies

Boya Xiao, Guo-He Lin, Bicheng Wang, 2022, BMC cancer.